1,990 results on '"Medical research -- Forecasts and trends -- Reports"'
Search Results
2. Research and Markets Offers Report: Cell Culture Market Global Outlook & Forecast 2024-2029
3. Research and Markets Issues Report: 3D Cell Culture Market - Global Outlook & Forecast 2024-2029
4. Research and Markets Offers Report: Gluten Intolerance Treatment Market
5. xxxx Gluten Intolerance Treatment Market
6. Transparency Market Research: Chronic Kidney Disease (CKD) Drugs Market Expected to Reach USD 23.8 Billion
7. Researchers at Max-Planck-Institute for Demographic Research Target Obesity (Projection of Us Adult Obesity Trends Based On Individual Bmi Trajectories)
8. Research and Markets Issues Report: Vaccine Contract Manufacturing Industry 2024-2035: The Advent of Virus-like Particles (VLPs)
9. Research and Markets Releases Report: Vaccine Contract Manufacturing Industry Report 2024-2035
10. Research and Markets Adds Report: Bromhidrosis Disease Treatment Strategic Research 2024
11. GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight
12. Research and Markets Adds Report: Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Market Forecast to 2029
13. Research and Markets Issues Report: Clinical Trial Supply and Logistics Market for Pharma 2024-2034
14. Research and Markets Offers Report: The World Market for Vaccines
15. Global Hematology Market to Exhibit Growth at a CAGR of ~8% by 2030 | DelveInsight
16. Global Veterinary Vaccines Market is Predicted to Cross USD 16 Billion by 2030 | DelveInsight
17. Alzheimer's Disease Therapeutics Market to Grow by USD 5.41 Billion (2024-2028), AI Redefines Market Landscape with Novel Biomarker Advancements - Technavio
18. Clinical Trials Market in the US to grow by USD 5 Billion from 2024-2028, driven by more drug trials, with AI redefining market trends - Technavio
19. Urea Cycle Disorder Treatment Market to Grow by USD 215.4 Million (2024-2028), Driven by Rising Prevalence, with AI Redefining Market Landscape - Technavio
20. U.S. Clinical Trials Market Size, Share & Trends Analysis Report 2025-2030
21. Patient Engagement Technology Market to grow by USD 37.41 Billion from 2024-2028, driven by rising chronic disease cases and AI's impact on market trends - Technavio
22. NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
23. Oligometastatic Disease Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Therapies, Companies by DelveInsight
24. $720 Mn+ Gluten Intolerance Treatment Market Trends, Opportunities and Forecasts 2020-2024 & 2025-2030 by Disorder Type, Sales Channel, Treatment Type, Region, & Country
25. $720 Mn+ Gluten Intolerance Treatment Market Trends, Opportunities and Forecasts 2020-2024 & 2025-2030 by Disorder Type, Sales Channel, Treatment Type, Region, & Country - ResearchAndMarkets.com
26. REM Sleep Behavior Disorder Market to Grow by USD 438.6 Million from 2024-2028, Driven by Rising Neurological Disorders and AI-Driven Market Trends - Technavio
27. $720 Mn+ Gluten Intolerance Treatment Market Trends, Opportunities and Forecasts 2020-2024 & 2025-2030 by Disorder Type, Sales Channel, Treatment Type, Region, & Country
28. Neurologic Disorders Therapeutics Strategic Business Report 2023-2030: Development of Precision Medicine and Targeted Therapies Strengthens Business Case
29. Clinical Trials Market Size to Reach $73.33 Billion By 2031 | CAGR 6.8%: The Insight Partners
30. Global Protein Chip Market to Surge at a CAGR of ~7% by 2030 | DelveInsight
31. Neurologic Disorders Therapeutics Strategic Business Report 2023-2030: Development of Precision Medicine and Targeted Therapies Strengthens Business Case
32. Post-Traumatic Stress Disorder (PTSD) Therapeutics Global Strategic Business Report 2024-2030 Featuring Apotex, AstraZeneca, Azevan, Bionomics, GSK, Novartis, Otsuka, Pfizer, and Tonix
33. Post-Traumatic Stress Disorder (PTSD) Therapeutics Global Strategic Business Report 2024-2030 Featuring Apotex, AstraZeneca, Azevan, Bionomics, GSK, Novartis, Otsuka, Pfizer, and Tonix
34. Research and Markets Adds Report: 3D Cell Cultures Technologies Report 2024
35. Reports Outline Drugs and Therapies Study Findings from AbbVie Inc. (Enrollment Forecast for Clinical Trials At the Planning Phase With Study-level Historical Data)
36. New Findings from Department of Psychology Describe Advances in Cardiovascular and Cerebrovascular Diseases (Projections of the Stroke Burden at the Global, Regional, and National Levels up to 2050 Based on the Global Burden of Disease Study ...)
37. Research and Markets Adds Report: Cell Culture Market Global Outlook & Forecast 2024-2029
38. Research and Markets Releases Report: 3D Cell Culture Market - Global Outlook & Forecast 2024-2029
39. New Type 1 Diabetes Findings from University 'Magna Graecia' Catanzaro Described (Forecasting Glucose Values for Patients With Type 1 Diabetes Using Heart Rate Data)
40. xxxx Gluten Intolerance Treatment Market
41. RIVM Researcher Focuses on Mental Health Diseases and Conditions (Public Health Challenges for 2050 in the Netherlands)
42. Transparency Market Research: Chronic Kidney Disease (CKD) Drugs Market Projected to Hit USD 23.8 Billion
43. Pneumococcal Vaccine Research Report 2024: Market Expected to Reach $12.932 Billion by 2029
44. AI in Life Sciences Market Poised for Explosive Growth with 27.9% CAGR Through 2029
45. U.S. IVD And LDT For Autoimmune Diseases Market Research 2024-2030: Rising Awareness of Autoimmune Disorders Fuels Demand for Innovative Diagnostic Solutions
46. Global Huntington's Disease Treatment Market Research 2024-2032 Featuring H Lundbeck, Pfizer, Bausch, Teva, Dr Reddy's, Sun Pharma, Hikma Pharma, Alnylam Pharma, Novartis, UniQure
47. Patient Engagement Tech Market to Grow by USD 37.4 Billion (2024-2028) with Chronic Disease Rise, AI's Influence on Market Trends - Technavio Report
48. Expanding Market for FYARRO in the Treatment of PEComa Through 2032: Key Dynamics and Competitive Analysis, Product Overview and Clinical Assessment, Regulatory Milestones and Developmental Activities - ResearchAndMarkets.com
49. ABBV-951 in Parkinson's Disease Forecasts and Impacts to 2032: Investigational Status and Clinical Advancements, Market Forecast and Clinical Assessment, Impact on Treatment Scenario - ResearchAndMarkets.com
50. Choroideremia Treatment Market Research 2024: Gene Therapy, Topical Carbonic Inhibitor, Dorzolamide, Lutein, Luxturna - Global Forecast to 2030
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.